Variables | Number (n = 73) |
---|---|
Age (years, mean ± SD) (range) | 55.8 ± 10.4 (34–76) |
Gender (%) | |
Male | 43 (58.9) |
Female | 30 (41.1) |
BMI (kg/m2, mean ± SD)(range) | 24.8 ± 3.2 (18.4–30.8) |
Distance from AV (cm, mean ± SD)(range) | 4.3 ± 2.0 (1–8) |
Histology (%) | |
Moderate | 59 (80.8) |
Poor/mucinous/signet | 14 (19.2) |
AJCC T stage (%) | |
T1–T2 | 28 (38.4) |
T3–T4 | 45 (61.6) |
AJCC N stage (%) | |
N0 | 40 (53.4) |
N1–N2 | 34 (46.6) |
Perineural invasion (%) | 23 (31.5) |
Lymphatic invasion (%) | 17 (23.3) |
Vascular invasion (%) | 16 (21.9) |
LPN metastasis (%) | 15 (20.5) |
Location of LPNM (%) | |
Alongside the internal iliac vessel region | 5 (6.8) |
Alongside the external iliac vessel region | 3 (4.1) |
Alongside the obturator region | 9 (12.3) |
The common iliac vessel region | 2 (2.7) |
LPND (%) | |
Unilateral dissection | 55 (75.3) |
Bilateral dissection | 18 (24.7) |
Mesorectal lymph nodes harvested(range) | 15.4 ± 8.0 (8–58) |
LPLNs harvested(range) | 9.0 ± 5.5 (5–38) |
Operative time (min, mean ± SD)(range) | 291.9 ± 69.4 (170–480) |
Estimated intraoperative blood loss (ml, mean ± SD)(range) | 87.3 ± 103.7 (10–300) |
Postoperative complications (%) | 14 (19.2) |
Postoperative hospital days (days, mean ± SD)(range) | 8.7 ± 4.8 (6–44) |
Adjuvant chemotherapy | 54 (74.0) |